Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 1
2000 2
2001 1
2002 2
2003 2
2004 2
2006 2
2007 8
2008 8
2009 6
2010 11
2011 10
2012 8
2013 3
2014 4
2015 3
2016 4
2017 4
2018 1
2019 5
2020 4
2021 2
2022 6
2023 3
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Segmental priapism.
Borrelli M, Glina S, Wroclawski ER, Celestino JC, Menezes de Goes G. Borrelli M, et al. Among authors: celestino jc. Urol Int. 1986;41(2):156-7. doi: 10.1159/000281187. Urol Int. 1986. PMID: 3727193 Free article.
Normal Risk Ovarian Screening Study: 21-Year Update.
Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC Jr. Han CY, et al. Among authors: celestino j. J Clin Oncol. 2024 Apr 1;42(10):1102-1109. doi: 10.1200/JCO.23.00141. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194613
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC Jr. Young Han C, et al. Among authors: celestino j. Br J Cancer. 2024 Mar;130(5):861-868. doi: 10.1038/s41416-023-02560-z. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195887 Free PMC article.
Robot-aided neurorehabilitation: a robot for wrist rehabilitation.
Krebs HI, Volpe BT, Williams D, Celestino J, Charles SK, Lynch D, Hogan N. Krebs HI, et al. Among authors: celestino j. IEEE Trans Neural Syst Rehabil Eng. 2007 Sep;15(3):327-35. doi: 10.1109/TNSRE.2007.903899. IEEE Trans Neural Syst Rehabil Eng. 2007. PMID: 17894265 Free PMC article. Review.
Long-term follow-up of levonorgestrel intrauterine device for atypical hyperplasia and early endometrial cancer reveals relapse characterized by immune exhaustion.
Bowen MB, Melendez B, Zhang Q, Yang RK, Fellman BM, Lawson BC, Adjei NN, Celestino J, Wani KM, Singh B, Urbauer DL, Lazar AJ, Lu KH, Wargo JA, Westin SN, Yates MS. Bowen MB, et al. Among authors: celestino j. Clin Cancer Res. 2024 Jun 26. doi: 10.1158/1078-0432.CCR-24-0362. Online ahead of print. Clin Cancer Res. 2024. PMID: 38922360
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
How JA, Dang M, Lee S, Fellman B, Westin SN, Sood AK, Fleming ND, Shafer A, Yuan Y, Liu J, Zhao L, Celestino J, Hajek R, Morgan MB, Parra ER, Laberiano Fernandez CD, Arrechedera CA, Solis Soto LM, Schmeler KM, Nick A, Lu KH, Coleman R, Wang L, Jazaeri AA. How JA, et al. Among authors: celestino j. Med. 2024 Aug 10:S2666-6340(24)00303-9. doi: 10.1016/j.medj.2024.07.022. Online ahead of print. Med. 2024. PMID: 39151421
[Elevaled lesions of the stomach].
Castillo TS, Campor J, Espejo H, Celestino JA. Castillo TS, et al. Among authors: celestino ja. G E N. 1976 Jan-Jun;30(3-4):183-8. G E N. 1976. PMID: 829857 Spanish.
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.
Handley KF, Sims TT, Bateman NW, Glassman D, Foster KI, Lee S, Yao J, Yao H, Fellman BM, Liu J, Lu Z, Conrads KA, Hood BL, Barakat W, Zhao L, Zhang J, Westin SN, Celestino J, Rangel KM, Badal S, Pereira I, Ram PT, Maxwell GL, Eberlin LS, Futreal PA, Bast RC Jr, Fleming ND, Conrads TP, Sood AK. Handley KF, et al. Among authors: celestino j. JAMA Netw Open. 2022 Oct 3;5(10):e2236626. doi: 10.1001/jamanetworkopen.2022.36626. JAMA Netw Open. 2022. PMID: 36239936 Free PMC article.
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses.
Irajizad E, Han CY, Celestino J, Wu R, Murage E, Spencer R, Dennison JB, Vykoukal J, Long JP, Do KA, Drescher C, Lu K, Lu Z, Bast RC, Hanash S, Fahrmann JF. Irajizad E, et al. Among authors: celestino j. Clin Cancer Res. 2022 Nov 1;28(21):4669-4676. doi: 10.1158/1078-0432.CCR-22-1113. Clin Cancer Res. 2022. PMID: 36037307 Free PMC article.
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.
Zhao L, Corvigno S, Ma S, Celestino J, Fleming ND, Hajek RA, Lankenau Ahumada A, Jennings NB, Thompson EJ, Tang H, Westin SN, Jazaeri AA, Zhang J, Futreal PA, Sood AK, Lee S. Zhao L, et al. Among authors: celestino j. Cancers (Basel). 2022 Jul 23;14(15):3589. doi: 10.3390/cancers14153589. Cancers (Basel). 2022. PMID: 35892848 Free PMC article.
92 results